Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

计划入组 353 人 · 首次发布于 2011 年 10 月 13 日

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

计划入组 3 人 · 首次发布于 2006 年 6 月 2 日

18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

计划入组 227 人 · 首次发布于 2007 年 8 月 6 日

Cannabidiol dry powder inhalation (MannKind Corporation/Receptor Life Sciences)

Inhaled Insulin Shows Promising Results in Type 1 Diabetes Management Over 30 Weeks

MannKind Corporation Receives FDA Approval for Afrezza Inhaled Insulin in Pediatric Diabetes Patients

MannKind and United Therapeutics Expand Partnership for Second Pulmonary Hypertension Inhaled Therapy